Enjoy complimentary customisation on priority with our Enterprise License!
The high throughput screening market size is estimated to grow by USD 19.9 billion at a CAGR (Compound Annual Growth Rate) of 12.12% between 2023 and 2028. The increasing prevalence of chronic diseases is driving the market, facilitating drug discovery through high-throughput methods such as target screening and compound profiling. Automation expedites screening protocols and assay platforms, aiding in laboratory robotics applications. This meets the demand for new drug molecules, particularly in pharmaceutical industry contexts.
A primary trend is the focus on promotional activities, addressing challenges in product visibility. Market players promote high-throughput assays through awareness programs, supporting market expansion.
For More HighligHTS About this Report, Download Free Sample in a Minute
The application segment includes target identification and validation, primary and secondary screening, toxicology assessment, and stem cell research. The end-user segment includes pharmaceutical and biotechnology companies, academic and research institutes, and CROs. The geography segment includes key regions such as North America, Europe, Asia, and Rest of World (ROW).
The market share growth by the target identification and validation segment will be significant during the forecast period. Target identification and validation is the primary stage of drug development. Moreover, factors such as a growing pipeline for biological candidates continued outsourcing from pharmaceutical companies, and increasing demand for accurate analytical details on drugs and process development by regulatory agencies are anticipated to drive the growth of the target identification and validation segment.
Get a glance at the market research and growth contribution of various segments Download the PDF Sample
The target identification and validation segment was valued at USD 7.04 billion in 2018. The advancements made in the target identification and validation of novel drug targets using different approaches, such as advanced bioinformatics tools and automated experimental designs, and the penetration of AI and ML algorithms will further enhance the growth of the segment. Therefore, all such factors are expected to foster the growth of the target identification and validation segment in the market during the forecast period.
For more insights on the market share of various regions Download PDF Sample now!
North America is estimated to contribute 40% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.
North America is the largest revenue contributor in the market due to the presence of key vendors, such as Bio-Rad Laboratories and Thermo Fisher Scientific in the region, that continually support a large number of pharmaceutical and biotechnology companies in the region through diversified portfolio offerings.
The forecast period indicates that the US and Canada will be the top revenue contributors in the region. This is due to their stable economies, robust infrastructure supporting drug launches, and substantial investments in research and development for new drugs. Personalized medicine in the US, based on patient physiologies, is transforming healthcare while increasing awareness of regenerative medicine is driving the adoption of technology. The US and Canada, being key countries in North America, are witnessing growing support for disease-related research from the biotechnology and pharmaceutical sectors.
The market is primarily driven by the increasing prevalence of chronic diseases within the Pharmaceutical and Biotechnology industries. Laboratory automation plays a pivotal role in HTS, allowing for rapid screening of large Compound Libraries using Screening assays, Biochemical assays, and Cell-based assays.
Trends in the market include advancements in High-throughput sequencing technologies, facilitating Target identification and Hit identification. Lead optimization techniques have also improved, leading to more efficient Assay development and Drug screening processes.
Challenges in the HTS market include the need for continuous innovation to enhance screening efficiency and accuracy. Additionally, managing large datasets generated from HTS assays poses challenges in data analysis and interpretation.
Overall, the HTS market continues to grow rapidly, driven by the demand for more efficient and cost-effective drug discovery solutions, and fueled by advancements in laboratory automation and screening technologies.
The increasing prevalence of chronic diseases is the key factor driving market growth. They are used for screening small molecules in the drug-finding approach, which allows different identification of candidates for the treatment of chronic conditions such as cancer, HIV, and cardiovascular diseases. The prevalence of these conditions is increasing across the globe, which is triggering the demand for products. The drug discovery process leverages automation to rapidly assess the biological or biochemical activity of a large number of drug-like compounds.
Moreover, it's useful in discovering ligands for receptors, enzymes, ion channels, or other pharmacological targets. Therefore, it is an asset to the drug discovery process, providing valuable insights and helping save time and money, which are expected to drive the high-throughput screening market. Thus, the high incidence of cancer is increasing the demand for new drug molecule screening, which is expected to drive the growth of the global market during the forecast period.
Increasing focus on promotional activities is the primary trend shaping market growth. The nature of the product and the end user segment makes it difficult for sellers to promote their products. Unlike other products, brand and product visibility play a limited role in selling. Advertising and marketing of these products is limited and HTS is very little known. However, key high-throughput screening market players have recognized this issue. Hence, they are promoting the use through their websites.
Furthermore, as advanced products are being developed, high-throughput screening market players are beginning to realize the importance of promotional activities and awareness programs, which are likely to support the growth of the market during the forecast period. Thus, such factors are expected to drive the growth of the market during the forecast period.
Import duty and distribution issues in developing countries is a challenge that affects market growth. The majority of manufacturers come from the US and European countries, such as the UK and Germany. On average, these suppliers have manufacturing or sales units in 3 to 5 countries. Therefore, other countries have to import tools. Almost all the major countries in APAC have high import duties for laboratory equipment, particularly China, India, and Bangladesh. The high import duties will discourage investors from importing them and setting up research facilities in these countries.
In addition, the complexity of logistics linked to the distribution of accessories, reagents, and consumables further adds to the suffering. The availability of safe third-party logistics is gradually helping manufacturers overcome this limitation, but it continues to be a significant factor adversely affecting the demand and use in developing countries. Hence, such factors may impede the growth of the market during the forecast period.
Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.
Agilent Technologies Inc.: The company offers products such as the Agilent RapidFire 400 high throughput mass spectrometry system.
The research report also includes detailed analyses of the competitive landscape of the market and information about 15 market companies, including:
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
The market revolutionizes biomedical research through cutting-edge Laboratory automation and advanced Screening assays. With vast Compound libraries and diverse Biochemical assays, researchers can efficiently screen Chemical compounds for drug discovery.
Cell-based assays and High-throughput sequencing enable rapid Pharmacological screening and Hit identification, leading to streamlined Lead optimization. High-throughput robotics and Automation systems enhance efficiency in Assay development and Drug screening.
From Screening techniques to Assay validation, the market offers robust Screening platforms and Assay optimization tools. Sample preparation and Data analysis techniques ensure accurate results using High-throughput equipment.
High-content screening and Compound screening expedite Hit validation and Lead identification, driving innovation in Bioassays and Screening efficiency. With applications in Clinical diagnostics and Biomarker discovery, high throughput screening accelerates Drug target identification and biomedical breakthroughs.
Industry trends and Technology advancements fuel market growth, offering diverse Screening applications and optimizing Assay formats. Through continuous Market analysis and report, stakeholders stay informed, fostering collaboration and innovation in biomolecular screening and laboratory techniques.
.
Market Scope |
|
Report Coverage |
Details |
Page number |
171 |
Base year |
2023 |
Historic period |
2018 - 2022 |
Forecast period |
2024-2028 |
Growth momentum & CAGR |
Accelerate at a CAGR of 12.12% |
Market growth 2024-2028 |
USD 19.9 billion |
Market structure |
Fragmented |
YoY growth 2023-2024(%) |
11.64 |
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
Performing market contribution |
North America at 40% |
Key countries |
US, Japan, China, Germany, and France |
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
Key companies profiled |
Agilent Technologies Inc., Aurora Biomed Inc., Axxam Spa, Beckman Coulter Inc., Bio Rad Laboratories Inc., Biomat Srl, BMG LABTECH GmbH, Charles River Laboratories International Inc., Corning Inc., Danaher Corp., DIANA Biotechnologies s.r.o, HighRes Biosolutions, JSR Life Sciences LLC, Lonza Group Ltd., Merck KGaA, NanoTemper Technologies GmbH, PerkinElmer Inc., Sygnature Discovery Ltd., Tecan Trading AG, and Thermo Fisher Scientific Inc. |
Market dynamics |
Parent market analysis,Market forecasting, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period |
Customization purview |
If our market growth analysis market report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
We can help! Our analysts can customize this market research report to meet your requirements.
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Application
7 Market Segmentation by End-user
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
Get lifetime access to our
Technavio Insights
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.